Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensified post-remission therapy in high-risk adult acute lymphoblastic leukemia with MRD monitoring
2004-001738-17Phase 3Completed
- Sponsor
- GIMEMA
- Start
- Jan 2005
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of prednisone, daunorubicin, vincristine, methotrexate, pegaspargase and 6 more in acute lymphoblastic leukemia (ALL), sponsored by GIMEMA. Started Jan 2005; status: completed.
02
Drugs
prednisonedaunorubicinvincristinemethotrexatepegaspargase
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on 2004-001738-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001738-17.